The Acute Myeloid Leukemia (AML) market is estimated to be valued at USD 1.74 billion in 2025 and is expected to reach USD 2.92 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.7% from 2025 to 2032. https://hallbook.com.br/blogs/719272/Acute-Myeloid-Leukemia-AML-Market-Growth-Driven-by-Innovative-Therapies